17Apr/26
Breaking the “Undruggable” Barrier: The Next Frontier in Targeting Nuclear Receptors via Protein Degradation
The pharmaceutical landscape is currently witnessing a tectonic shift. For decades, the “occupancy-driven” model—where a small molecule sits in a protein’s active site to inhibit its function—has been the gold standard. However,Read More…